CDIP Antibody

ProSci
Product Code: PSI-5059
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-5059-0.02mg0.02mg£150.00
Quantity:
PSI-5059-0.1mg0.1mg£449.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence (IF)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)

Images

1 / 3
Western blot analysis of CDIP in human brain lysate with CDIP antibody at (A) 0.25 and (B) 0.5 μg/mL.
2 / 3
Immunohistochemistry of CDIP in mouse brain tissue with CDIP antibody at 2.5 μg/mL.
3 / 3
Immunofluorescence of CDIP1 in mouse brain tissue with CDIP1 antibody at 20 μg/mL.

Western blot analysis of CDIP in human brain lysate with CDIP antibody at (A) 0.25 and (B) 0.5 μg/mL.
Immunohistochemistry of CDIP in mouse brain tissue with CDIP antibody at 2.5 μg/mL.
Immunofluorescence of CDIP1 in mouse brain tissue with CDIP1 antibody at 20 μg/mL.

Further Information

Additional Names:
CDIP Antibody: I1, CDIP, LITAFL, C16orf5, Cell death-inducing p53-target protein 1, Cell death involved p53-target
Application Note:
CDIP antibody can be used for detection of CDIP by Western blot at 0.25 - 0.5 μg/mL. Antibody can also be used for immunohistochemistry starting at 2.5 μg/mL. For immunofluorescence start at 20 μg/mL.

Antibody validated: Western Blot in human samples; Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested.
Background:
CDIP Antibody: The p53 tumor-suppressor gene integrates numerous signals that control cell life and death; loss of its functions contributes to the development of most cancers. CDIP is a novel pro-apoptotic target gene whose inhibition abrogates p53-mediated apoptotic responses. Overexpression of CDIP induced apoptosis in transfected cells while siRNA suppression of caspase-8 mRNA blocked this CDIP-induced apoptosis, indicating that the CDIP-dependent apoptosis pathway proceeds through extrinsic cell death pathway. CDIP may thus represent a novel target for drug design to maximize p53 response and sensitize tumor cells to cancer therapy. Multiple isoforms of CDIP are known to exist.
Background References:
  • Guimaraes DP and Hainaut P. TP53: a key gene in human cancer. Biochimie2002; 84:83-93.
  • Brown L, Ongusaha PP, Kim H-H, et al. CDIP, a novel pro-apoptotic gene, regulates TNFa-mediated apoptosis in a p53-dependent manner. EMBO J.2007; 26:3410-22.
Buffer:
CDIP Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Homology:
Predicted species reactivity based on immunogen sequence: Rat: (100%), Bovine: (100%)
Immunogen:
CDIP antibody was raised against a 19 amino acid synthetic peptide near the center of human CDIP.

The immunogen is located within amino acids 70 - 120 of CDIP.
NCBI Gene ID #:
29965
NCBI Official Name:
cell death inducing p53 target 1
NCBI Official Symbol:
CDIP1
NCBI Organism:
Homo sapiens
Physical State:
Liquid
Protein Accession #:
NP_037531
Protein GI Number:
118344450
Purification:
CDIP Antibody is affinity chromatography purified via peptide column.
Research Area:
Apoptosis
Swissprot #:
Q9H305
User NOte:
Optimal dilutions for each application to be determined by the researcher.

Related Products

Product NameProduct CodeSupplier 
CDIP PeptidePSI-5059PProSci Summary Details